Bỏ qua đến nội dung chính
Back to home
Tech 1 min read

The biohacking trend and the limits of testing technology on our bodies

A new milestone from The Verge's "Optimizer" newsletter raises questions about the limits of using technology and biopharmaceuticals to transform our lives.

Tier 1 · sources 99% confidence Reviewed
Sources theverge.com

In the latest tech newsletter from The Verge, senior reviewer Victoria Song opens up a deep discussion on the biohacking trend and the boundaries people are willing to push to improve their physical well-being. Through her specialized newsletter titled "Optimizer," she focuses on dissecting new devices and remedies marketed as life-changing.

Background

According to The Verge, today's health tech market is saturated with biometric trackers and supplements promising to optimize human performance. Discussions surrounding the "Enhanced Games"—an athletic event that allows performance-enhancing drugs—alongside regulations from the US Food and Drug Administration (FDA), are pushing the biohacking wave to a whole new level. Users are increasingly faced with numerous options to experiment directly on their own bodies, despite unknown long-term consequences.

Developments

Author Victoria Song shares that she has spent time researching the pharmaceuticals and technologies people are putting into their bodies to self-optimize. Smart wearables and supplementary compounds constantly flood the market with spectacular promises of life transformation. However, the line between proactive health management and the abuse of unproven therapies is becoming increasingly blurred, demanding a more critical and realistic look from consumers.

Why it matters

The biohacking trend is no longer a far-off concept but is gradually reaching the tech-savvy community in Vietnam. Understanding safety boundaries, the regulatory role of authorities like the FDA, and the actual impact of health-tracking devices is absolutely essential. Consumers need to maintain a healthy skepticism toward hyped marketing campaigns from manufacturers to avoid turning themselves into guinea pigs for incomplete technologies.